Drug Topics
JULY 3, 2024
Individuals who ate diets that aligned closer to DASH and Mediterranean guidelines had lower levels of plasminogen activator inhibitor-1 and homocysteine biomarkers.
STAT
JULY 3, 2024
Remember when we thought Covid was a two-week illness? So does Michael Peluso, assistant professor of medicine at the University of California, San Francisco. He recalls the rush to study acute Covid infection, and the crush of resulting papers. But Peluso, an HIV researcher, knew what his team excelled at: following people over the long term.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
JULY 3, 2024
To address behavioral health access barriers for students, California launched a program to offer incentive payments to Medi-Cal managed care plans to build capacity for behavioral health services in K-12 schools.
STAT
JULY 3, 2024
A new observational study on Wednesday reported for the first time a potential link between Novo Nordisk’s GLP-1 drugs Ozempic and Wegovy and an eye condition that can cause vision loss. After hearing anecdotes of patients on the diabetes and obesity drugs experiencing nonarteritic anterior ischemic optic neuropathy, or NAION, researchers at Massachusetts Eye and Ear analyzed data from a registry of patients at their institution to see if there was a broad trend.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JULY 3, 2024
The test can be performed in settings that operate under the Clinical Laboratory Improvement Amendments waiver, including community pharmacies.
STAT
JULY 3, 2024
When, in April, the federal government began requiring some cows to be tested for a strain of avian flu before their herds could be moved across state lines, it seemed like an obvious step to try to track and slow the virus that had started spreading among U.S. dairy cattle. But Joe Armstrong, a veterinarian at the University of Minnesota extension school, feared the U.S.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
JULY 3, 2024
Six abstracts presented at the American Diabetes Association 84th Scientific Sessions explored how different interventions or factors can impact type 2 diabetes (T2D) management.
pharmaphorum
JULY 3, 2024
GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID-19 jabs.
STAT
JULY 3, 2024
GSK and CureVac have restructured an ongoing partnership that gives the British pharma giant control over the development of experimental mRNA-based Covid and flu vaccines, the companies said Wednesday. CureVac, the German biotech that focuses on mRNA vaccines, will receive an initial payment of €400 million upfront ($430 million) from GSK, and is eligible for another €1.05 billion ($1.1 billion) in future payments if certain milestones are hit.
pharmaphorum
JULY 3, 2024
Beacon Therapeutics raises $170m for a pivotal trial of its gene therapy for X-linked retinitis pigmentosa, an inherited cause of blindness
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Med Ed 101
JULY 3, 2024
JE is a 77-year-old male. He reports significant constipation despite the use of three laxative medications. In this case summary, I will outline the most important medications that can contribute to constipation polypharmacy. Past medical history includes: The current constipation medications he is taking include: Other medications include: Constipation Polypharmacy Review The first thing I […] The post Constipation Polypharmacy appeared first on Med Ed 101.
STAT
JULY 3, 2024
While the bogus science of eugenics — the idea that the human race can be improved through selective reproduction — has been nearly universally discredited, remnants of this belief system are still alive and well in modern research. One of the most glaring examples of this is the work of academic psychologist Richard Lynn. Lynn’s work focused on researching human intelligence and the “national IQ” database he compiled on IQ scores from many countries has been c
Pharmacy Times
JULY 3, 2024
Palliative care may help reduce symptoms and improve quality-of-life for patients with cardiovascular disease.
Fierce Pharma
JULY 3, 2024
After more than a decade with no treatment advances for chronic obstructive pulmonary disease (COPD), two have been approved by regulators on either side of the Atlantic within a week. | After more than a decade with no treatment advances for chronic obstructive pulmonary disease (COPD), two have been approved by regulators on either side of the Atlantic within a week.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
JULY 3, 2024
Top Biden administration officials have withdrawn from an industry body formed to set safety standards and frameworks for evaluating how artificial intelligence models are used in health care. Micky Tripathi , the national coordinator for health information technology and acting chief AI officer at the Department of Health and Human Services, and Troy Tazbaz, director of Digital Health Center of Excellence at the Food and Drug Administration, have stepped down as nonvoting members of the Coaliti
Fierce Healthcare
JULY 3, 2024
LAS VEGAS—Amazon is betting big on its pharmacy arm, with the retail giant aiming to bring its focus on ease of use for consumers to the prescription drug space. | LAS VEGAS—Amazon is betting big on its pharmacy arm, with the retail giant aiming to bring its focus on ease of use for consumers to the prescription drug space.
STAT
JULY 3, 2024
Top of the morning to you, and a fine one it is. The skies are clear, the sun is shining, and all sorts of birds are chirping outside our window. Moreover, there is a one-day break tomorrow on this side of the pond due to a holiday. So to celebrate, yes, we are firing up the coffee kettle to indulge in another cup of stimulation. Our choice today is maple bourbon.
pharmaphorum
JULY 3, 2024
EU is first to approve Sanofi and Regeneron's Dupixent for COPD, ending a 10-year hiatus in new therapies
STAT
JULY 3, 2024
More than two dozen Medicare Advantage insurers received higher quality marks for 2024, based on a STAT review of new data released July 2 by the federal government. Ten health insurance companies, including UnitedHealth Group’s UnitedHealthcare and CVS Health’s Aetna, received critical upgrades in some of their offerings that will allow them to earn hundreds of millions of dollars in extra taxpayer-funded bonuses.
Pharmacy Times
JULY 3, 2024
Validating language proficiency in bilingual pharmacists is crucial for patient safety and communication.
STAT
JULY 3, 2024
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Taking time off is nice, but returning for a July 4-shortened workweek is a bit discombobulating. Speaking of which, I’m landing in your inbox a day early because of the holiday.
Pharmaceutical Technology
JULY 3, 2024
Academic institutions and nonprofit organisations are jumping in to save access to complex gene therapies.
Pharmacy Times
JULY 3, 2024
As dupilumab garners positive clinical trial results in patients with chronic obstructive pulmonary disease, it is increasingly important that pharmacists educate themselves on the treatment.
pharmaphorum
JULY 3, 2024
J&J’s multiple myeloma CAR-T Carvykti improves survival when used as a second-line or later therapy, raising the pressure on BMS’ rival Abecma
Pharmacy Times
JULY 3, 2024
Pharmacists are leveraging tools, campaigns, and free samples to educate patients about medication-induced photosensitivity and the importance of sun protection.
Pharmafile
JULY 3, 2024
Eli Lilly has announced that the US Food and Drug Administration (FDA) has approved Kisunla (donanemab-azbt, 350mg/20ml once-monthly injection for IV infusion) for the treatment of adult patients with early symptomatic Alzheimer’s disease (AD). The post Eli Lilly’s Kisunla approved by FDA for Alzheimer’s treatment appeared first on Pharmafile.
pharmaphorum
JULY 3, 2024
Frontiers Health, a prominent event in health innovation, has unveiled the foundational pillars that will define its legacy and future trajectory. The announcement of these pillars precedes their global conference, scheduled for the 17th and 18th of October in Berlin.
Pharmafile
JULY 3, 2024
GSK and CureVac have announced that they have restructured their existing collaboration into a license agreement, which is intended to allow both companies to prioritise investment and focus their respective mRNA development programmes. The post GSK and CureVac to restructure collaboration into licensing agreement appeared first on Pharmafile.
Fierce Healthcare
JULY 3, 2024
It is estimated that up to 20% of people globally are neurodivergent. Many neurodivergent individuals, including those with autism, have unique sensory needs. | This week on "Podnosis," Anastassia Gliadkovskaya explores how Jefferson Health's new pavilion incorporates innovative, inclusive features for neurodivergent individuals.
STAT
JULY 3, 2024
Artificial intelligence has the potential to revolutionize how drugs are discovered and change how hospitals deliver care to patients. But AI also comes with the risk of irreparable harm and perpetuating historic inequities. Would-be health care AI regulators have been spinning in circles trying to figure out how to use AI safely. Industry bodies, investors, Congress, and federal agencies are unable to agree on which voluntary AI validation frameworks will help ensure that patients are safe.
Fierce Healthcare
JULY 3, 2024
Function pockets $53M for personalized health testing backed by celeb investors Matt Damon, Pedro Pascal and Kevin Hart hlandi Wed, 07/03/2024 - 16:19
Hospital Pharmacy Europe
JULY 3, 2024
Pharmacists are becoming an increasingly important part of the emergency department multidisciplinary team. One area in which they can make a big difference to patient care is safeguarding, and this is the subject of a recent qualitative study. Lead author Daniel Greenwood discusses the context around ED pharmacist practitioners in the UK and elsewhere, how they fit into the safeguarding process and the training and education required to ensure best practice.
The Checkup by Singlecare
JULY 3, 2024
Adderall (amphetamine/dextroamphetamine) is a brand-name prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat attention deficit hyperactivity disorder ( ADHD ) and narcolepsy. Adderall is generally used in combination with other treatment methods, such as behavioral therapy and educational interventions. In some cases, people who take Adderall may notice that after some time, it feels like the medicine is not working as well as it used to.
Pharmaceutical Commerce
JULY 3, 2024
The Stelara biosimilar will be commercialized by Sandoz, and is expected to launch by February 2025 for multiple indications, including for the treatment of adult patients with active psoriatic arthritis.
Expert insights. Personalized for you.
191 
Let's personalize your content